about
Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's diseaseAcute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence.Brain structural signatures of negative symptoms in depression and schizophreniaReduction in ventral striatal activity when anticipating a reward in depression and schizophrenia: a replicated cross-diagnostic finding.Social and spatial heterogeneity in psychosis proneness in a multilevel case-prodrome-control studyAbnormal Frontostriatal Activity During Unexpected Reward Receipt in Depression and Schizophrenia: Relationship to AnhedoniaThe Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description.The Epidemiology of First-Episode Psychosis in Early Intervention in Psychosis Services: Findings From the Social Epidemiology of Psychoses in East Anglia [SEPEA] Study.Ethnic Minority Status, Age-at-Immigration and Psychosis Risk in Rural Environments: Evidence From the SEPEA Study.Olanzapine as the ideal "trip terminator"? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance-related psychotic symptoms.Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease.Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease.Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy.Transitioning Bodies. The Case of Self-Prescribing Sexual Hormones in Gender Affirmation in Individuals Attending Psychiatric Services.Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol DependenceAcute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol DependenceA translation of "L´Elettroshock" by Cerletti & Bini, with an introductionUtility of biomarkers to improve the diagnosis and treatment of schizophrenia
P50
Q28247008-6B66FCD7-87CB-4432-85D1-E5AE1BCD1E1BQ33652844-FCC96AF3-CA2B-4062-899E-FE514BE3C8FDQ34093633-8F7411F3-1D96-440D-A0D8-B283E8D65BA5Q35996129-E6CEB6A8-4120-4E62-AF6F-5F276F42D613Q36532831-86B204CB-722A-4E55-A2F8-F9AC6EBA3A94Q36763174-13044664-1E50-4A0D-A12E-7EAA5E323913Q38977208-3516D69A-1B9C-4B69-BDF2-E2430C260C83Q39257773-2E045047-5B4D-4920-96F0-1E25212CD5A4Q40196545-B70232D3-35AF-4C08-9CE5-31CB54321238Q40689652-9CE29292-183C-4BE4-A7D8-258C640B43A9Q44169486-E8123787-4FC2-4B50-8DD5-EB7109B0BF0EQ44555815-0A3D6582-B895-4451-9B08-7380DEAD8E01Q46528864-FD3EA6E6-8CCB-4954-B224-F00DAFE213F0Q55378623-0D68145A-9656-4C49-BB9C-589C12B1838BQ60055004-2B8F9034-2665-4E56-A4D7-38713AFD5BEFQ60055005-63C08546-0514-4C94-8E3E-85A5E173B24DQ60055006-88BE8E8E-DD57-4E14-ADC0-7AFA9D5916AFQ60055007-197EC559-DD85-40C7-A8E7-842B27580F6D
P50
description
researcher ORCID ID = 0000-0003-2258-4089
@en
wetenschapper
@nl
name
Antonio Metastasio
@ast
Antonio Metastasio
@en
Antonio Metastasio
@es
Antonio Metastasio
@nl
type
label
Antonio Metastasio
@ast
Antonio Metastasio
@en
Antonio Metastasio
@es
Antonio Metastasio
@nl
prefLabel
Antonio Metastasio
@ast
Antonio Metastasio
@en
Antonio Metastasio
@es
Antonio Metastasio
@nl
P106
P1153
6506196094
P21
P31
P496
0000-0003-2258-4089